Next Article in Journal
Transcriptional Regulation of Cardiac Genes Balance Pro- and Anti-Hypertrophic Mechanisms in Hypertrophic Cardiomyopathy
Previous Article in Journal
Idiopathic Restrictive Cardiomyopathy - Perspectives from Genetics Studies. Is It Time to Redefine These Disorders?
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cardiogenetics
Volume 2
Issue 1
10.4081/cardiogenetics.2012.e6
cardiogenetics-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Cardiogenetics is published by MDPI from Volume 10 Issue 2 (2020). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Combined Use of In Silico and In Vitro Splicing Assays for Interpretation of Genomic Variants of Unknown Significance in Cardiomyopathies and Channelopathies

by
Hervé Crehalet
1,
Gilles Millat
1,2,
Juliette Albuisson
3,
Véronique Bonnet
1,
Isabelle Rouvet
4,
Robert Rousson
1 and
Dominique Bozon
1,*
1
Laboratoire de Cardiogénétique moléculaire, CBPE– Hospices Civils de Lyon, Bron
2
EA4612, Université Claude Bernard Lyon 1, Lyon
3
Laboratoire de Génétique Moléculaire, CHU, Hôtel-Dieu, Nantes
4
Centre de Biotechnologie Cellulaire, CBPE– Hospices Civils de Lyon, Bron
*
Author to whom correspondence should be addressed.
Cardiogenetics 2012, 2(1), e6; https://doi.org/10.4081/cardiogenetics.2012.e6
Submission received: 27 March 2012 / Revised: 22 May 2012 / Accepted: 23 May 2012 / Published: 5 June 2012
Versions Notes

Abstract

The identification of molecular anomalies in patients with inherited arrhythmias or cardiomyopathies is a multi challenge due to: i) the number of genes involved; ii) the number of polymorphisms and the fact that most mutations are private; and iii) the variable degree of penetrance which complicates family segregation study. Consequently, a number of unclassified variants (UV) are found in patients’ DNA and some (outside the canonical GT/AG) may affect splicing. Mutational screening on the most prevalent genes involved in arrythmias syndromes or in cardiomyopathies was performed on a cohort made up of 740 unrelated French index probands. To identify splice variants among the identified UVs, a combination of available in silico and in vitro tools were used since transcript is not available. Using this approach, 10 previously identified UVs were reclassified as disease-causing mutations and, more precisely, as haploinsufficiency mutations rather than dominant-negative mutations. Most of them (7 of 10) were observed in MYBPC3. Our study highlighted the importance of the combined use of in silico and in vitro splicing assays to improve the prediction of the functional impact of identified genetic variants. The primary challenge now, with new sequencing technologies, is to distinguish between background polymorphisms and pathogenic mutations. Since splice site mutations can account for almost 50% of disease-causing mutations, recognizing them from among other variations is essential.
Keywords: cardiomyopathies; arrhythmia syndromes; splice mutations; molecular diagnosis cardiomyopathies; arrhythmia syndromes; splice mutations; molecular diagnosis

Share and Cite

MDPI and ACS Style

Crehalet, H.; Millat, G.; Albuisson, J.; Bonnet, V.; Rouvet, I.; Rousson, R.; Bozon, D. Combined Use of In Silico and In Vitro Splicing Assays for Interpretation of Genomic Variants of Unknown Significance in Cardiomyopathies and Channelopathies. Cardiogenetics 2012, 2, e6. https://doi.org/10.4081/cardiogenetics.2012.e6

AMA Style

Crehalet H, Millat G, Albuisson J, Bonnet V, Rouvet I, Rousson R, Bozon D. Combined Use of In Silico and In Vitro Splicing Assays for Interpretation of Genomic Variants of Unknown Significance in Cardiomyopathies and Channelopathies. Cardiogenetics. 2012; 2(1):e6. https://doi.org/10.4081/cardiogenetics.2012.e6

Chicago/Turabian Style

Crehalet, Hervé, Gilles Millat, Juliette Albuisson, Véronique Bonnet, Isabelle Rouvet, Robert Rousson, and Dominique Bozon. 2012. "Combined Use of In Silico and In Vitro Splicing Assays for Interpretation of Genomic Variants of Unknown Significance in Cardiomyopathies and Channelopathies" Cardiogenetics 2, no. 1: e6. https://doi.org/10.4081/cardiogenetics.2012.e6

APA Style

Crehalet, H., Millat, G., Albuisson, J., Bonnet, V., Rouvet, I., Rousson, R., & Bozon, D. (2012). Combined Use of In Silico and In Vitro Splicing Assays for Interpretation of Genomic Variants of Unknown Significance in Cardiomyopathies and Channelopathies. Cardiogenetics, 2(1), e6. https://doi.org/10.4081/cardiogenetics.2012.e6

Article Metrics

Back to TopTop